Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)--Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Dubé, Michael P.; Stein, James H.; Aberg, Judith A.; Fichtenbaum, Carl J.; Gerber, John C.; Tashima, Karen T.; Keith Henry, W.; Currier, Judith S.; Sprecher, Dennis; Glesby, Marshall J.
September 2003
Clinical Infectious Diseases;9/1/2003, Vol. 37 Issue 5, p613
Academic Journal
Focuses on recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group for the evaluation and management of dyslipidemia in HIV infected adults receiving antiretroviral therapy. Information about dyslipidemia; Details of the recommendations.


Related Articles

  • Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. del Amo, J.; del Romero, J.; Barrasa, A.; Pérez-Hoyos, S.; Rodríguez, C.; Díez, M.; Garcí, S.; Soriano, V.; Castilla, J. // Sexually Transmitted Infections;Aug2002, Vol. 78 Issue 4, p255 

    Objective: To study HIV progression from seroconversion over a 15 year period and measure the population effectiveness of highly active antiretroviral therapy (HAART). Methods: A cohort study of people with well documented dates of seroconversion. Cumulative risk of AIDS and death were...

  • Nelfinavir: A Review of its Therapeutic Efficacy in HIV Infection. Jarvis, B.; Faulds, D. // Drugs;Jul1998, Vol. 56 Issue 1, p147 

    Nelfinavir is a selective inhibitor of HIV protease, the enzyme responsible for post-translational processing of HIV propeptides. In the presence of the drug, immature, noninfectious virus particles are produced. Nelfinavir in combination with nucleoside reverse transcriptase inhibitors,...

  • Lopinavir/Ritonavir: A Review of its Use in the Management of HIV Infection. Cvetkovic, Risto S.; Goa, Karen L. // Drugs;2003, Vol. 63 Issue 8, p769 

    Lopinavir is a novel protease inhibitor (PI) developed from ritonavir. Coadministration with low-dose ritonavir significantly improves the pharmacokinetic properties and hence the activity of lopinavir against HIV-1 protease. Coformulated lopinavir/ritonavir was developed for ease of...

  • HIV wages war on 'miracle' drugs. Cohen, Philip // New Scientist;8/17/2002, Vol. 175 Issue 2356, p22 

    Reports the need to develop drugs to combat resistance to HIV virus in the U.S. Details on the screening of HIV patients for resistance; Efficacy of antiviral drugs against AIDS; Side effects of antiviral agents.

  • CD8+ T-cell-mediated Non-cytolytic Suppression of Human Immunodeficiency Viruses. C. Vella; R.S. Daniels // Current Drug Targets - Infectious Disorders;Jun2003, Vol. 3 Issue 2, p97 

    Major Histocompatibility (MHC)-restricted Cytotoxic T-Lymphocytes (CTL) kill Human Immunodeficiency Virus (HIV)-infected cells. In addition, activated CD8+ T-lymphocytes from HIV-infected individuals suppress virus replication in vitro by producing antiviral factor (CAF). The effector...

  • HIV/AIDS: Various Issues Explored. Barton, E. N. // West Indian Medical Journal;2010 Special Issue, Vol. 59 Issue 4, p345 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including one by A. Gomez and C. Alexis-Thomas on perspectives of leaders in Grenada on the prevalence of HIV-AIDS patients, one by P. R. Byam and colleagues on the causes of...

  • Synthesis and Evaluation of Anti-HIV-1 and Anti-HSV-1 Activities of 4H-[1,2,4]-Triazolo[ 1,5-a]pyrimidin-5-one Derivatives. Abdul-Hafez, Atef A.; Elsherief, Hosny A.H.; Jo, Michiko; Kurokawa, Masahiko; Shiraki, Kimiyasu; Kawahata, Takuya; Otake, Toru; Nakamura, Norio; Hattori, Masao // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Nov2002, Vol. 52 Issue 11, p833 

    In a one pot procedure, 18 compounds of 7-(substituted phenyl)-2-substituted-6,7-dihydro-4H-[1,2,4]triazolo[1,5-a] pyrimidin-5-one derivatives (16-33) have been synthesized. 3(5)-Amino-5(3)-substituted-l,2,4-triazole derivatives (7-12) were used as synthones which were cyclocondensed by fusion...

  • In This Issue.  // Clinical Infectious Diseases;12/15/2007, Vol. 45 Issue 12, pi 

    The article discusses various reports published within the issue including one about Panton-Valentine leukocidin and another about the usage of antiretroviral therapy in HIV-infected patients with kidney disease.

  • SOFT-GEL SAQUINAVIR NOW AVAILABLE.  // AIDS Patient Care & STDs;Feb1998, Vol. 12 Issue 2, p146 

    Reports that the soft gel formulation of saquinavir (Fortovase) was approved for the market to treat human immunodeficiency virus (HIV) infection in adults in combination with other antiretroviral agents. When saquinavir was introduced to treat HIV; Reported side effects from patients receiving...

  • ritonavir:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p193 

    An encyclopedia entry for ritonavir, which is an HIV protease inhibitor that works by interfering with the reproductive cycle of HIV, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics